Aravive Inc - Common / Ordinary Stock (ARAV)

CUSIP: 03890D108

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / Common / Ordinary Stock
Total 13F shares
2,136,294
Share change
+205,725
Total reported value
$15,036,000
Put/Call ratio
0%
Price per share
$7.04
Number of holders
26
Value change
+$1,889,671
Number of buys
13
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 03890D108?
CUSIP 03890D108 identifies ARAV - Aravive Inc - Common / Ordinary Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aravive Inc - Common / Ordinary Stock (ARAV) as of Q1 2019

As of 31 Mar 2019, Aravive Inc - Common / Ordinary Stock (ARAV) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,136,294 shares. The largest 10 holders included Samsara BioCapital, LLC, BAKER BROS. ADVISORS LP, Artal Group S.A., BlackRock Inc., VANGUARD GROUP INC, Board of Trustees of The Leland Stanford Junior University, DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, UBS Group AG, and NF Trinity Capital (Hong Kong) Ltd. This page lists 26 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.